- Companies
- Prim
Prim Valuation Multiples
Prim is valued at $242M as of October 2026, a 0.8x revenue multiple. In the last 12 months, Prim revenue was $297M and Prim EBITDA was $40M.
Prim Overview
About Prim
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
Founded
1966
HQ
Employees
563
Website
Sectors
Financials (LTM)
EV
$230M
Valuation Multiples
Start free trialPrim Financials
Prim reported last 12-month revenue of $297M and EBITDA of $40M.
In the same LTM period, Prim generated $40M in EBITDA and $20M in net income.
Revenue (LTM)
Prim P&L
In the most recent fiscal year, Prim reported revenue of $282M and EBITDA of $37M.
Prim is profitable as of last fiscal year, with gross margin of 51%, EBITDA margin of 13%, and net margin of 7%.
Financial data powered by Morningstar, Inc.
Prim Stock Performance
Prim has current market cap of $242M, and enterprise value of $230M.
Market Cap Evolution
Prim's stock price is $14.23.
Prim share price decreased by 0.3% in the last 30 days, and by 11.0% in the last year.
Prim has an EPS (earnings per share) of $1.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $230M | $242M | -0.3% | -0.3% | -7.6% | -11.0% | $1.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPrim Valuation Multiples
Prim trades at 0.8x EV/Revenue multiple, and 5.7x EV/EBITDA.
EV / Revenue (LTM)
Prim Financial Valuation Multiples
As of October 9, 2026, Prim has market cap of $242M and EV of $230M.
Prim has a P/E ratio of 12.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Prim Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Prim Margins & Growth Rates
Prim grew revenue by 12% and EBITDA by 16% in the last fiscal year.
In the most recent fiscal year, Prim reported gross margin of 51%, EBITDA margin of 13%, and net margin of 7%.
Prim Margins
Prim Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Prim Operational KPIs
Prim's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.5M for the same period.
Prim's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Prim's Rule of X is 44% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Prim Competitors
Prim competitors include Stille, Tristel, Paragon Care, Embecta, Jin Medical International, Oriola, Bastide Le Confort Médical, KORU Medical Systems, Mercator Medical and Universal Vision.
Most Prim public comparables operate across Medical Supplies.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $57M | $12M | 3.7x | 3.0x | 18.2x | 14.3x | |||
| $61M | $15M | 4.3x | 3.8x | 17.7x | 13.6x | |||
| $2.6B | $34M | 0.2x | 0.2x | 12.3x | 5.9x | |||
| $1.1B | $284M | 1.5x | 1.6x | 5.6x | 5.1x | |||
| $21M | $1M | 15.4x | - | 274.8x | - | |||
| $2.1B | ($14M) | 0.1x | 0.2x | (8.1x) | 3.2x | |||
| $550M | $113M | 0.9x | 0.9x | 4.3x | 4.2x | |||
| $41M | ($2M) | 3.3x | 2.9x | (63.7x) | 107.1x | |||
This data is available for Pro users. Sign up to see all Prim competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Prim
| When was Prim founded? | Prim was founded in 1966. |
| Where is Prim headquartered? | Prim is headquartered in Spain. |
| How many employees does Prim have? | As of today, Prim has over 563 employees. |
| Is Prim publicly listed? | Yes, Prim is a public company listed on Bolsa de Madrid. |
| What is the stock symbol of Prim? | Prim trades under PRM ticker. |
| When did Prim go public? | Prim went public in 1997. |
| Who are competitors of Prim? | Prim main competitors include Stille, Tristel, Paragon Care, Embecta, Jin Medical International, Oriola, Bastide Le Confort Médical, KORU Medical Systems, Mercator Medical, Universal Vision. |
| What is the current market cap of Prim? | Prim's current market cap is $242M. |
| What is the current revenue of Prim? | Prim's last 12 months revenue is $297M. |
| What is the current revenue growth of Prim? | Prim revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Prim? | Current revenue multiple of Prim is 0.8x. |
| What is the current EBITDA of Prim? | Prim's last 12 months EBITDA is $40M. |
| What is Prim's EBITDA margin? | Prim's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Prim? | Current EBITDA multiple of Prim is 5.7x. |
| How many companies Prim has acquired to date? | Prim hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Prim has invested to date? | Prim hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Prim
Lists including Prim
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




